Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Fructo-Oligosaccharide
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : CEN Biotech
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Fructo-Oligosaccharide is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
January 12, 2024
Lead Product(s) : Fructo-Oligosaccharide
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : CEN Biotech
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Non Digestible Carbohydrates
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Sponsor : BioFortis
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Non Digestible Carbohydrates is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Prediabetic State.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 23, 2021
Lead Product(s) : Non Digestible Carbohydrates
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Sponsor : BioFortis
Deal Size : Inapplicable
Deal Type : Inapplicable